More importantly, SOX9 with up-regulated expression was indicated poor prognosis in colorectal cancer, glioma and lung cancer (Liu et al. 2017; Bruun et al. 2014; Zhou et al. 2012). The gene discussed is SOX9; the disease is central nervous system cancer.